J Robert Gillespie Selected Research

methioninyl adenylate

10/2012

Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Robert Gillespie Research Topics

Disease

9	African Trypanosomiasis (Nagana) 02/2020 - 10/2008
4	Infections 01/2020 - 05/2011
3	Neglected Diseases 02/2020 - 01/2015
2	Trypanosomiasis 01/2021 - 07/2017
2	Cryptosporidiosis 01/2021 - 01/2019
1	Cysts 01/2020
1	Giardiasis 01/2020
1	Tuberculosis (Tuberculoses) 01/2018
1	Gram-Positive Bacterial Infections 11/2017
1	Visceral Leishmaniasis (Kala Azar) 07/2017
1	Leishmaniasis 01/2016
1	Chagas Disease (American Trypanosomiasis) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 08/2015

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 10/2008
6	Methionine-tRNA LigaseIBA 01/2020 - 05/2011
4	Antiparasitic Agents (Antiparasitics)IBA 01/2017 - 07/2013
3	EnzymesIBA 01/2018 - 10/2012
2	imidazopyridineIBA 01/2021 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2017 - 07/2012
1	Anti-Infective Agents (Microbicides)IBA 01/2021
1	pyrimidineIBA 01/2021
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2021
1	LuciferasesIBA 01/2020
1	nanolucIBA 01/2020
1	nitazoxanide (NTZ)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Adenine FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2017
1	compound 20IBA 07/2017
1	AminesIBA 01/2017
1	BenzamidesIBA 01/2017
1	GNF6702IBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	aminoquinoloneIBA 10/2012
1	methioninyl adenylateIBA 10/2012
1	Methionine (L-Methionine)FDA Link 10/2012
1	Glycogen Synthase Kinase 3IBA 10/2008

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2008